We provide distribution and consultancy services to pharmaceutical companies focusing on treatments for rare diseases and orphan drugs.
Our aim is to make available innovative treatments in the Turkish pharmaceutical market.
Our expert and experienced team meet your highest expectations through the delivery of services within Turkey and closely working with our international partners.
Hemophilia is a bleeding disorder that results in inadequate clotting of the blood. The most common types of hemophilia are Hemophilia-A and Hemophilia-B.
Read moreWe introduce products into the Turkish pharmaceutical market by collaborating with international pharmaceutical companies focused on the development of treatments for rare diseases and orphan drugs.
Read more